Recombinant Campylobacter concisus Translation Initiation Factor IF-2 (infB), partial refers to a genetically engineered protein fragment derived from the infB gene of C. concisus, which encodes the bacterial translation initiation factor IF-2. This factor is essential for ribosome assembly, initiator tRNA (fMet-tRNA) binding, and GTP hydrolysis during the initiation phase of protein synthesis . The "partial" designation indicates that only specific functional domains (e.g., GTPase or tRNA-binding regions) are expressed, rather than the full-length protein.
Domain Independence: The C-terminal tRNA-binding domain (C2) operates independently of GTPase activity in bacterial IF-2 , implying that partial recombinant constructs retain functionality.
Chaperone Activity: IF-2’s NTD in E. coli assists ribosome assembly during cold shock , a feature potentially exploitable in recombinant systems.
KEGG: cco:CCC13826_1495
STRING: 360104.CCC13826_1495
Translation Initiation Factor IF-2 mediates the binding of formylmethionyl-tRNA (fMet-tRNA) to the 30S ribosomal subunit during translation initiation. The protein recognizes the formyl group on the initiator tRNA, positioning it at the P-site of the ribosome in a GTP-dependent manner. Following GTP hydrolysis after 50S subunit joining, IF-2 is released, allowing translation elongation to proceed. In pathogenic bacteria like C. concisus, IF-2 may play additional roles in adaptation to stressful environments encountered during host infection.
Campylobacter concisus has emerged as an oral and intestinal pathogen associated with inflammatory bowel disease (IBD) and Crohn's disease, while C. jejuni and C. coli are established primarily as gastrointestinal pathogens. C. concisus possesses a relatively smaller genome (1.8-2.1 Mb), suggesting evolutionary adaptation through versatile respiratory pathways and multifunctional enzymes . The species demonstrates significant strain-to-strain variability, with strains isolated from chronic intestinal diseases showing higher invasive potential than those from acute gastroenteritis . Additionally, C. concisus can grow under both microaerobic and anaerobic conditions, utilizing various N- or S-oxides as terminal electron acceptors during anaerobic respiration .
Campylobacter concisus exhibits considerable genetic heterogeneity across strains isolated from different clinical sources and disease states. Genomic analyses reveal that strains from chronic intestinal diseases possess significantly higher invasive potential than those from acute diseases or healthy controls . This variation in virulence appears linked to specific plasmids . Certain genes, such as bisA, are present in intestinal strains (13826 and 51562) but absent in oral strains (33237), contributing to different metabolic capabilities and virulence factors . This genetic diversity explains the heterogeneity observed in clinical outcomes associated with C. concisus infection and highlights the importance of strain-specific characterization in research.
For recombinant production of bacterial translation factors like IF-2, E. coli-based expression systems are predominantly employed. Common vectors include pET series plasmids with T7 promoters for high-level inducible expression. When expressing potentially toxic proteins, tightly regulated systems such as pBAD (arabinose-inducible) may be preferable. E. coli BL21(DE3) and its derivatives are frequently used due to their reduced protease activity. For challenging proteins, specialized strains providing rare codons (Rosetta) or cold-adapted chaperones (Arctic Express) can enhance soluble expression. Purification typically involves affinity chromatography using His6 tags, often with protease cleavage sites for tag removal post-purification. When expressing C. concisus proteins specifically, codon optimization may be necessary due to the significant differences in codon usage between Campylobacter and E. coli.
The genetic diversity observed between C. concisus strains isolated from different clinical sources likely extends to variations in translation machinery proteins including IF-2. These variations may manifest as amino acid substitutions affecting IF-2's binding affinity for GTP, fMet-tRNA, or ribosomal components. Strains with enhanced invasive potential from chronic intestinal diseases might possess IF-2 variants optimized for protein synthesis under inflammatory conditions, similar to those observed in Crohn's disease patients .
To investigate these variations, researchers should implement:
Comparative sequence analysis of infB genes across strains
Recombinant expression and purification of IF-2 variants
Structural characterization using X-ray crystallography or cryo-EM
Functional assays measuring GTPase activity and translation initiation rates
Assessment of protein stability under varying pH and oxidative stress conditions
Methodological approaches should include site-directed mutagenesis to test the functional significance of strain-specific amino acid differences and ribosome binding assays to quantify interaction dynamics between variant IF-2 proteins and ribosomes.
Given that C. concisus infection activates immune pathways including interleukin-12 production, proteasome activation, and NF-κB signaling , investigating IF-2's potential role in these processes requires sophisticated experimental approaches:
Protein-protein interaction studies:
Co-immunoprecipitation using recombinant IF-2 and host cell lysates
Surface plasmon resonance to quantify binding affinities
Proximity labeling (BioID/APEX) to identify in vivo interaction partners
Immunological assays:
Comparative studies:
Localization studies:
Immunofluorescence microscopy with anti-IF-2 antibodies during infection
Fractionation of infected cells to track IF-2 distribution
These approaches would determine whether IF-2 directly interacts with host immune components or if its role in pathogenesis is primarily through maintaining bacterial protein synthesis during infection.
C. concisus must adapt to varying oxygen tensions throughout the gastrointestinal tract, growing under both microaerobic and anaerobic conditions . This adaptation likely extends to its translation machinery, including IF-2. Research suggests C. concisus possesses sophisticated mechanisms for managing oxidative stress, exemplified by the BisA protein's dual role in respiration and protein methionine sulfoxide repair .
To investigate redox effects on IF-2:
| Experimental Approach | Methodology | Expected Outcome |
|---|---|---|
| Stability assessment | Differential scanning fluorimetry under varying redox conditions | Thermal stability profiles under oxidizing/reducing environments |
| Activity measurement | GTPase assays and in vitro translation initiation | Quantitative differences in activity correlated with redox state |
| Modification mapping | Mass spectrometry analysis of purified IF-2 | Identification of oxidation-sensitive residues (Met, Cys) |
| Repair systems interaction | Pull-down assays with methionine sulfoxide reductases | Physical interaction between IF-2 and repair enzymes like BisA |
| Mutational analysis | Site-directed mutagenesis of oxidation-sensitive residues | Impact of non-oxidizable variants on function |
Understanding how IF-2 maintains functionality during oxidative stress could explain C. concisus persistence during intestinal inflammation, where reactive oxygen species are abundant, and potentially reveal targets for therapeutic intervention.
Computational approaches offer powerful tools for predicting how strain-specific variations in C. concisus IF-2 might impact function:
Sequence analysis:
Multiple sequence alignment of infB genes from diverse C. concisus strains
Phylogenetic analysis correlating sequence clusters with clinical sources
Identification of positively selected residues under evolutionary pressure
Structural prediction:
Homology modeling based on resolved bacterial IF-2 structures
Ab initio modeling for divergent regions
Molecular dynamics simulations (100ns-1μs) to assess conformational differences
Functional prediction:
GTP binding site analysis
Ribosome and tRNA interaction surface mapping
Identification of strain-specific surface properties
Integration with experimental data:
This computational-experimental pipeline could identify strain-specific adaptations in IF-2 that contribute to the varying pathogenic potential observed among C. concisus strains from different disease states .
Studying post-translational modifications (PTMs) of C. concisus IF-2 requires an integrated proteomic approach:
Sample preparation strategies:
Multiple proteases (trypsin, chymotrypsin, Glu-C) to maximize sequence coverage
Enrichment methods for specific PTMs (TiO₂ for phosphorylation, antibody-based for acetylation)
Differential alkylation to preserve in vivo redox states
Mass spectrometry approaches:
High-resolution LC-MS/MS with ETD fragmentation to preserve labile modifications
Top-down proteomics for intact protein analysis to detect modification combinations
Parallel reaction monitoring (PRM) for targeted quantification of modified peptides
Specific considerations for C. concisus:
Validation methods:
Site-directed mutagenesis of modified residues
Functional assays comparing wild-type and modification-site mutants
Structural analysis of modification impact on protein conformation
This comprehensive approach would reveal how PTMs regulate IF-2 function in response to the changing environments encountered during C. concisus infection and colonization.
Differentiating direct IF-2 effects from broader genomic influences requires a systematic approach:
By isolating the IF-2 variable while controlling other genomic factors, researchers can establish causal relationships between specific IF-2 variants and phenotypic differences observed among C. concisus strains.
When analyzing IF-2 activity across multiple C. concisus strains, robust statistical frameworks are essential:
Experimental design considerations:
Balanced designs with sufficient biological replicates (minimum n=5 per strain)
Inclusion of technical replicates to quantify measurement error
Blocking factors to control for batch effects
Statistical models:
Mixed-effects linear models accounting for fixed (strain type, growth conditions) and random effects (biological variation)
ANCOVA when controlling for covariates like growth rate or protein expression level
Non-parametric approaches when normality assumptions are violated
Multiple testing corrections:
Benjamini-Hochberg procedure for controlling false discovery rate
Tukey's HSD for post-hoc comparisons between multiple strains
Advanced analytical techniques:
Principal component analysis for multivariate activity data
Hierarchical clustering to identify strain groupings based on activity profiles
Bayesian methods for incorporating prior knowledge about IF-2 function
Validation strategies:
Cross-validation of predictive models
Bootstrap resampling to establish robust confidence intervals
Independent verification experiments with distinct methodologies
Appropriate statistical analysis is particularly important given the known heterogeneity among C. concisus strains , which can introduce substantial biological variability.
Isotope labeling techniques provide powerful tools for studying IF-2 dynamics during infection:
Protein synthesis and turnover:
SILAC (Stable Isotope Labeling with Amino Acids in Cell Culture) with heavy isotope-labeled amino acids (¹³C₆-lysine, ¹³C₆-arginine)
Pulse-chase experiments to determine IF-2 half-life during different infection phases
Quantification of synthesis/degradation rates during stress response
Structural dynamics:
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) to map conformational changes
Limited proteolysis coupled with MS to identify flexible regions
Cross-linking Mass Spectrometry (XL-MS) to capture interaction interfaces
Protein-protein interactions:
Isotope-labeled crosslinking reagents to capture transient interactions
Proximity-dependent labeling with isotope-coded tags
Co-immunoprecipitation with isotope-labeled antibodies
In vivo applications:
These techniques should be applied within physiologically relevant models that recapitulate the intestinal environment, including appropriate oxygen tension and pH conditions that C. concisus would naturally encounter .
| Challenge | Cause | Solution |
|---|---|---|
| Poor expression | Codon bias between C. concisus and E. coli | Use codon-optimized synthetic gene; employ Rosetta or CodonPlus E. coli strains |
| Protein insolubility | Improper folding, hydrophobic regions | Lower induction temperature (16-18°C); use solubility-enhancing tags (SUMO, MBP); co-express chaperones |
| Truncated products | Large size of IF-2 (~100 kDa) | Reduce expression rate with weaker promoters; optimize ribosome binding site strength |
| RNA contamination | Nucleic acid binding properties of IF-2 | Include high salt (500-750 mM NaCl) and RNase in lysis buffer; add nuclease treatment step |
| Loss of activity | Conformational changes during purification | Include stabilizing agents: glycerol (10-20%), reducing agents (DTT/TCEP), and GTP (100-500 μM) |
| Proteolytic degradation | Sensitive regions in IF-2 structure | Add protease inhibitor cocktail; minimize purification time; maintain samples at 4°C |
| Poor yield | Toxicity to expression host | Use tightly regulated expression systems; express in cell-free systems if necessary |
| Aggregation during storage | Protein instability | Flash-freeze small aliquots in liquid nitrogen with 25% glycerol; avoid repeated freeze-thaw cycles |
Each of these challenges requires a tailored approach, and often multiple strategies must be combined for successful recombinant production of functional C. concisus IF-2.
Cell-based assays to evaluate IF-2 variants' impact on C. concisus virulence should include:
Adhesion and invasion assays:
Host cell response measurements:
Barrier function assessment:
Transepithelial electrical resistance (TEER) measurements
FITC-dextran permeability assays
Immunostaining for tight junction proteins
Translation impact analysis:
Puromycin incorporation to measure global protein synthesis
Polysome profiling to assess translation efficiency
Metabolic labeling with ³⁵S-methionine
Advanced models:
Co-culture systems with immune and epithelial cells
Intestinal organoids from patient biopsies
Microfluidic gut-on-chip platforms
These assays should be conducted using isogenic strains differing only in IF-2 sequence to directly attribute phenotypic differences to IF-2 variants.
Creating conditional modifications of the essential infB gene requires specialized approaches:
Inducible expression systems:
Engineer a merodiploid strain with native infB and an inducible copy
Use tetracycline-responsive or iron-regulated promoters
CRISPR-Cas9 targeting of native copy after establishing inducible expression
Post-translational control:
Fusion of degron tags (auxin-inducible or temperature-sensitive) to IF-2
Small-molecule induced protein destabilization
Split protein complementation systems
Targeted mutagenesis:
Recombineering with single-stranded DNA oligonucleotides
Lambda Red recombination system adapted for C. concisus
Allelic exchange vectors with counterselectable markers
Considerations for C. concisus:
Validation strategies:
qRT-PCR to confirm transcriptional changes
Western blotting to verify protein levels
Growth curves to assess physiological impact
Ribosome profiling to measure translation effects
Each approach must be carefully validated, as even partial reduction of IF-2 function may cause pleiotropic effects that complicate interpretation of results.
Modeling C. concisus IF-2 interactions with the intestinal environment requires systems that recapitulate key physiological features:
Advanced culture systems:
Intestinal organoids derived from human stem cells
Microfluidic gut-on-chip platforms with peristaltic movement
Transwell co-cultures with differentiated intestinal epithelium
Environmental parameter control:
Host-pathogen interaction components:
Analytical approaches:
Real-time monitoring of bacterial gene expression using reporter constructs
Proteomic analysis of IF-2 modifications under varying conditions
Microscopy to track bacterial localization and host cell interactions
Comparative studies:
These complex models provide more physiologically relevant contexts for studying how IF-2 contributes to C. concisus adaptation and virulence in the human intestinal environment.